NL-OMON52018尚未招募不适用
Generation of urothelial cancer organoids to investigate tumor biology in organoids and to perform drug sensitivity testing. - Urothelial cancer organoids
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 117
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Age >= 18 years at time of inclusion
- •Written informed consent
- •Able to read and understand the patient information
- •Mentally and physically able to participate according to the treating
排除标准
- •Known HIV-infection or other serious infectious disease which can be
- •transferred by one of the biomaterials.
研究者
相似试验
进行中（未招募）
不适用
Evaluation if and how many circulating tumor cells can be found in the blood of patients with urothelial cancer who have been treated with platinum based chemotherapyCirculating tumor cells in urothelial cancer patients relapsing after or refractory to platinum based first line chemotherapyEUCTR2013-000124-34-ATPD Dr. Maria De Santis
尚未招募
不适用
Propagation of organoids from urology tumorsrothelial carcinoma, renal cancer, prostata cancer, penile cancerC60C61C64C65C66C67C68Malignant neoplasm of penisMalignant neoplasm of prostateMalignant neoplasm of kidney, except renal pelvisMalignant neoplasm of renal pelvisMalignant neoplasm of ureterMalignant neoplasm of bladderMalignant neoplasm of other and unspecified urinary organsDRKS00030035niversitätsklinikum Ulm, Klinik für Urologie und Kinderurologie100
已完成
不适用
Circulating tumour cells in bladder cancer patients treated with chemotherapy and radical cystectomy – enumeration, characterization and evaluation of prognostic value (the CIRCH-study)rothelial carcinomaCancerISRCTN72499664und University182
已完成
不适用
Development of urothelial cancer-Specific mRNA and miRNA Assay in Human Urinary Exosomes and MicrovesiclesBladder CancerJPRN-UMIN000030054Hokkaido University Graduate School of Medicine600
招募中
不适用
Generation of circulating tumor cell derived organoids through enrichment by leukapheresis - A novel drug screening system in metastatic prostate cancerprostate cancerNL-OMON46104Erasmus MC, Universitair Medisch Centrum Rotterdam79